 |
|
Drug's epilepsy-prevention effect may be widely applicable
June 02, 2009A drug with potential to prevent epilepsy caused by a genetic condition may also help prevent more common forms of epilepsy caused by brain injury, according to researchers at Washington University School of Medicine in St. Louis.
Scientists found that the FDA-approved drug rapamycin blocks brain changes believed to cause seizures in rats. In a paper last year, the same group showed that rapamycin prevents brain changes in mice triggered by one of the most common genetic causes of epilepsy, tuberous sclerosis (TS).
"We hope to shift the focus from stopping seizures to preventing the brain abnormalities that cause seizures in the first place, and our results in the animal models so far have been encouraging," says senior author Michael Wong, M.D., Ph.D.
The study was published in The Journal of Neuroscience on May 27.
One percent of the population has epilepsy, which can result from genetic mutations, brain injuries and environmental insults. According to Wong, one-third of that group does not respond well to current anti-seizure medications.
"Researchers have traditionally tested potential epilepsy drugs on animals that were already having seizures," Wong says. "We may be able to improve our success rate by stepping back a little and trying to find a treatment that can halt the disease process prior to the start of seizures."
In earlier studies of TS, Wong and others showed that proteins involved in TS overactivate mTOR (mammalian target of rapamycin), a powerful regulatory protein. Wong speculated that mTOR might influence proteins involved in communication between brain cells, which could explain why TS causes seizures.
To test the theory, he gave rapamycin to mice with a TS gene mutation. The drug binds to mTOR, reducing its ability to activate other genes and proteins. Mice that received the drug were seizure-free and lived longer.
For the new study, Ling-Hui Zeng, Ph.D., a postdoctoral fellow, studied an animal model of epilepsy created by giving rats a drug known as kainate. Exposure to the drug initially causes a prolonged seizure. A few days later, the rats begin having spontaneous seizures. Research has previously shown that kainate causes brain cell death and the creation of new brain cells, and that some surviving brain cells grow multiple new branches, a phenomenon called mossy fiber sprouting. Scientists have speculated that this new and erratic growth of nerve cell branches may help promote the continuous chaotic nerve cell firing that takes place during seizures.
Zeng began her studies by showing that kainate causes an increase in a marker for mTOR activity during the initial seizure; this increase returned as rats began to develop spontaneous seizures days later and suggested that rapamycin might help prevent brain changes that underlie seizures.
When Zeng gave the rats rapamycin prior to kainate, the rats still had the initial seizure, but brain cell death, new brain cells and mossy fiber sprouting all decreased, and the later spontaneous seizures were also significantly reduced. Rats that received rapamycin after the initial seizure caused by kainate still lost and gained brain cells, but they had less mossy fiber sprouting and experienced fewer subsequent seizures.
"The fact that rapamycin had beneficial effects even after the first seizure is particularly exciting, because it suggests that if similar phenomena occur in the human brain, treating patients with mTOR inhibitors after a brain injury might reduce the chances of developing epilepsy," says Wong. "This may be particularly important for the surge of veterans returning with traumatic brain injuries from Iraq and Afghanistan."
Rapamycin is currently being evaluated in clinical trials as a treatment for the brain tumors caused by TS. Wong believes the new paper will add impetus for trials to test rapamycin and other mTOR inhibitors as epilepsy prevention drugs.
Washington University School of Medicine
The study was published in The Journal of Neuroscience on May 27.
One percent of the population has epilepsy, which can result from genetic mutations, brain injuries and environmental insults. According to Wong, one-third of that group does not respond well to current anti-seizure medications.
"Researchers have traditionally tested potential epilepsy drugs on animals that were already having seizures," Wong says. "We may be able to improve our success rate by stepping back a little and trying to find a treatment that can halt the disease process prior to the start of seizures."
In earlier studies of TS, Wong and others showed that proteins involved in TS overactivate mTOR (mammalian target of rapamycin), a powerful regulatory protein. Wong speculated that mTOR might influence proteins involved in communication between brain cells, which could explain why TS causes seizures.
To test the theory, he gave rapamycin to mice with a TS gene mutation. The drug binds to mTOR, reducing its ability to activate other genes and proteins. Mice that received the drug were seizure-free and lived longer.
For the new study, Ling-Hui Zeng, Ph.D., a postdoctoral fellow, studied an animal model of epilepsy created by giving rats a drug known as kainate. Exposure to the drug initially causes a prolonged seizure. A few days later, the rats begin having spontaneous seizures. Research has previously shown that kainate causes brain cell death and the creation of new brain cells, and that some surviving brain cells grow multiple new branches, a phenomenon called mossy fiber sprouting. Scientists have speculated that this new and erratic growth of nerve cell branches may help promote the continuous chaotic nerve cell firing that takes place during seizures.
Zeng began her studies by showing that kainate causes an increase in a marker for mTOR activity during the initial seizure; this increase returned as rats began to develop spontaneous seizures days later and suggested that rapamycin might help prevent brain changes that underlie seizures.
When Zeng gave the rats rapamycin prior to kainate, the rats still had the initial seizure, but brain cell death, new brain cells and mossy fiber sprouting all decreased, and the later spontaneous seizures were also significantly reduced. Rats that received rapamycin after the initial seizure caused by kainate still lost and gained brain cells, but they had less mossy fiber sprouting and experienced fewer subsequent seizures.
"The fact that rapamycin had beneficial effects even after the first seizure is particularly exciting, because it suggests that if similar phenomena occur in the human brain, treating patients with mTOR inhibitors after a brain injury might reduce the chances of developing epilepsy," says Wong. "This may be particularly important for the surge of veterans returning with traumatic brain injuries from Iraq and Afghanistan."
Rapamycin is currently being evaluated in clinical trials as a treatment for the brain tumors caused by TS. Wong believes the new paper will add impetus for trials to test rapamycin and other mTOR inhibitors as epilepsy prevention drugs.
Washington University School of Medicine
Epilepsy Current Events and Epilepsy News RSSGreater certainty in monitoring 3 therapeutic medications is facilitated by new CRMs
To help bring greater certainty to the measurement of medication levels in a patient's bloodstream for three drugs with narrow therapeutic ranges, the U.S. Pharmacopeial Convention (USP) is releasing new certified reference materials (CRMs).
Theory about long and short-term memory questioned by UCL scientists
The long-held theory that our brains use different mechanisms for forming long-term and short-term memories has been challenged by new research from UCL, published today in PNAS.
Developmental delay could stem from nicotinic receptor deletion
The loss of a gene through deletion of genetic material on chromosome 15 is associated with significant abnormalities in learning and behavior, said a consortium of researchers led by Baylor College of Medicine (www.bcm.edu) in a report that appears online today in the journal Nature Genetics.
Protein critical for insulin secretion may be contributor to diabetes
A cellular protein from a family involved in several human diseases is crucial for the proper production and release of insulin, new research has found, suggesting that the protein might play a role in diabetes.
Packages of care for epilepsy in low- and middle-income countries
In the second in a six part series on treating mental health problems in resource-poor settings, Caroline Mbuba and Charles Newton (Centre for Geographic Medicine Research, Kenya Medical Research Institute, Kilifi, Kenya) discuss "packages of care" for treating epilepsy.
Study pinpoints key mechanism in brain development, raising question about use of antiseizure drug
Researchers at the Stanford University School of Medicine have identified a key molecular player in guiding the formation of synapses - the all-important connections between nerve cells - in the brain.
tudy: The new buzz on detecting tinnitus
It's a ringing, a buzzing, a hissing or a clicking - and the patient is the only one who can hear it. Complicating matters, physicians can rarely pinpoint the source of tinnitus, a chronic ringing of the head or ears that can be as quiet as a whisper or as loud as a jackhammer.
Researchers find a key mechanism in the development of nerve cells
Chaos brews in the brains of newborns: the nerve cells are still bound only loosely to each other.
How mitochondrial gene defects impair respiration, other major life functions
Researchers are delving into abnormal gene function in mitochondria, structures within cells that power our lives. Mitochondria are the place where energy is generated from the most basic molecules of food. Because this function is essential to life, defects in mitochondria may affect a wide range of organ systems in humans and animals.
Pancreatic fat levels may help predict diabetes, UT Southwestern researchers say
Researchers have long suspected that overweight people tend to have large fat deposits in their pancreases, but they've been unable to confirm or calculate how much fat resides there because of the organ's location. Until now.
More Epilepsy Current Events and Epilepsy News Articles
 |
Epilepsy: Patient and Family Guide by M.D. Orrin Devinsky (Author) Taking the lead from real patients' questions and insights, this new edition of a best-selling guide gives must-have information to those diagnosed with epilepsy — the most common neurological disorder in children, adults, and the elderly. Written by a leading expert, this guide answers common questions, assuages patient's fears, and encourages epileptics to take an active role in their medical care. |
 |
Treating Epilepsy Naturally : A Guide to Alternative and Adjunct Therapies by Patricia Murphy (Author) Hard-to-find information on epilepsy, presented by an author living successfully with the condition Drugs commonly used to treat epilepsy have some extremely harmful side effects. Treating Epilepsy Naturally is an empathetic, practical, empowering look at treatment options, lifestyle choices, and ways of living well. Written by an author who has been successfully living with it herself for most of her adult life, this comprehensive guide offers alternative treatments to replace and to complement traditional therapies and sound advice to find the right health practitioner for you. |
 |
Seizures and Epilepsy in Childhood: A Guide (Johns Hopkins Press Health Book) by John M. Freeman MD (Author), Eileen P. G. Vining MD (Author), Diana J. Pillas (Author) The award-winning Seizures and Epilepsy in Childhood is the standard resource for parents in need of comprehensive medical information about their child with epilepsy. Now in its third edition, this highly praised book has been thoroughly revised and updated to reflect the latest approaches to the diagnosis and treatment of epilepsy in childhood, including the use of the ketogenic diet as a treatment for children who either do not respond to traditional drug therapy or who suffer intolerable side effects from medications. In addition to providing up-to-date information about new diagnostic techniques as well as new drugs, diet, and surgical treatments, the authors have included a chapter addressing routine health care for children with epilepsy and a new chapter on... |
 |
Living Well with Epilepsy and Other Seizure Disorders: An Expert Explains What You Really Need to Know by Carl W. Bazil (Author) |
 |
"Medical Alert Emergency ID Bracelet - ""Epilepsy"" By Apex Healthcare Products" by Apex Healthcare Products Provides a brief description summarizing a few key medical factsEmergency personnel are trained to look for a medical ID tag in an emergencyPlease check out our other products from Rock Ridge Sales! |
 |
Epilepsy: A Comprehensive Textbook (3-volume set) by Jerome Engel (Editor), Timothy A Pedley (Editor), Jean Aicardi (Editor), Marc A Dichter (Editor), Solomon Moshé (Editor) Written and edited by world-renowned authorities, this three-volume work is, to quote a reviewer, "the definitive textbook about seizures and epilepsy". This Second Edition is thoroughly updated and gives you a complete print and multimedia package: the three-volume set plus access to an integrated content Website. More than 300 chapters cover the spectrum of biology, physiology, and clinical information, from molecular biology to public health concerns in developing countries. Included are detailed discussions of seizure types and epilepsy syndromes; relationships between physiology and clinical events; psychiatric and medical comorbidity; conditions that could be mistaken for epilepsy; and an increasing range of pharmacologic, surgical, and alternative therapies, including vagus nerve... |
 |
"...First Do No Harm" Starring: Meryl Streep, Fred Ward, Seth Adkins, Allison Janney, Margo Martindale Directed By: Jim Abrahams Award-winning actress Meryl Streep (Best Actress, SOPHIE'S CHOICE, KRAMER VS. KRAMER, THE BRIDGES OF MADISON COUNTY) delivers a powerful and uplifting performance in this story of one family's strength and courage in a time of extreme crisis. Plunged into emotional and financial hardship, a devoted mother (Streep), a hardworking father (Fred Ward -- CHAIN REACTION, CORKY ROMANO) and the rest of this close-knit family face a decision that will change their lives forever. As time and options begin to run out, they must find the courage to overcome incredible odds. Widely praised by critics -- you'll find this compelling story of determination and hope both entertaining and inspirational! |
 |
Epilepsy: A New Approach by Adrienne Richard (Author), Joel Reiter (Author) This book is a unique collaboration between a gifted writer with epilepsy and a skilled physician who has brought new insight into the treatment of this condition. At the age of twenty-six, when Adrienne Richard was seven months pregnant, she was diagnosed with epilepsy. For years she took anticonvulsant drugs to control her seizures, but she wanted to wean herself from the powerful drugs if she could. During the first ten years without medication she had only one seizure. Her goal was to live seizure-free. Ms. Richard practiced yoga, biofeedback, and mind/body techniques in the eighties to help her reach that goal. While writing an article for a magazine based in California, she learned of Dr. Joel Reiter, who was exploring epilepsy self-care in his clinical practice and through his... |
 |
Seized: Temporal Lobe Epilepsy as a Medical, Historical, and Artistic Phenomenon by Eve LaPlante (Author) "Fascinating account of medical research...LaPlante shows how a brain scar may cause bizarre aggressive or sexual behavior-and works of profound creative imagination." —Howard Gardner "Readers intrigued by Oliver Sacks' Man Who Mistook His Wife For A Hat will welcome LaPlante's book...Thoughtful...Highly recommended." —Library Journal "LaPlante's descriptions of the human brain are wonderfully concrete, and her empathy for epilepsy's victims is clear." —Kirkus Review |
 |
Beyond my Control: One Man's Struggle with Epilepsy, Seizure Surgery & Beyond by Stuart McCallum (Author) Stuart Ross McCallum shares a true account of his battle with epilepsy-beginning with the peculiar sensations he experienced as a teenager that led to his diagnosis and concluding with his eventual recovery from a temporal lobe lobectomy.McCallum vividly describes his twenty-year journey of living with epilepsy and how this unpredictable disease has not only impacted his life but the lives of everyone around him. For years he operated a business and managed his staff while battling an ever-increasing number of seizures. As his condition worsened and his postseizure responses became more intense, he was often prone to violent outbursts that threatened his safety as well as the safety of those in his inner circle. McCallum shares how the perception of the disease and the socially... |
| © 2009 BrightSurf.com |